Combination chemotherapy with the M-2 protocol (BCNU, cyclophosphamide, vincristine, melphalan, and prednisone) for chronic lymphocytic leukemia (stages III and IV).

Case, D C; Porensky, R S; Fanning, J P

Case, D C; Porensky, R S; Fanning, J P.

Oncology ; 42(6): 350-3, 1985.

Article in En | MEDLINE | ID: mdl-4069549

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Leukemia, Lymphoid/drug therapy; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols/adverse effects; Carmustine/administration & dosage; Cyclophosphamide/administration & dosage; Humans; Leukemia, Lymphoid/pathology; Melphalan/administration & dosage; Middle Aged; Neoplasm Staging; Prednisone/administration & dosage; Prognosis; Vincristine/administration & dosage

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Lymphoid / Antineoplastic Combined Chemotherapy Protocols Type of study: Guideline / Prognostic_studies Limits: Adult / Aged / Humans / Middle aged Language: En Journal: Oncology Year: 1985 Document type: Article

Search on Google

Add to My VHL

XML

PubMed Links